Alerus Financial NA Invests $3.69 Million in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Posted by on Jun 13th, 2023

Alerus Financial NA purchased a new position in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Rating) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 47,420 shares of the company’s stock, valued at approximately $3,686,000. Alerus Financial NA owned approximately 0.73% of VanEck Pharmaceutical ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. JPMorgan Chase & Co. bought a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter worth $46,000. Banque Cantonale Vaudoise bought a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter worth $56,000. Activest Wealth Management bought a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter worth $70,000. Blair William & Co. IL grew its stake in shares of VanEck Pharmaceutical ETF by 341.0% in the fourth quarter. Blair William & Co. IL now owns 882 shares of the company’s stock worth $69,000 after purchasing an additional 682 shares during the last quarter. Finally, International Assets Investment Management LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the first quarter worth $279,000.

VanEck Pharmaceutical ETF Stock Up 0.1 %

Shares of VanEck Pharmaceutical ETF stock opened at $77.12 on Tuesday. VanEck Pharmaceutical ETF has a twelve month low of $66.59 and a twelve month high of $80.62. The stock has a market cap of $388.68 million, a price-to-earnings ratio of 16.59 and a beta of 0.72. The company’s fifty day moving average is $78.05 and its 200 day moving average is $77.39.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 10th. Shareholders of record on Tuesday, April 4th were given a dividend of $0.664 per share. The ex-dividend date was Monday, April 3rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.44%. This is a boost from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.24.

VanEck Pharmaceutical ETF Profile

(Get Rating)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

Read More

Want to see what other hedge funds are holding PPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Pharmaceutical ETF (NASDAQ:PPH – Get Rating).

Institutional Ownership by Quarter for VanEck Pharmaceutical ETF (NASDAQ:PPH)

Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.